Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis

A single center study of 433 patients

D. Caramazza, Kebede Begna, N. Gangat, R. Vaidya, S. Siragusa, D. L. Van Dyke, C. Hanson, Animesh D Pardanani, Ayalew Tefferi

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

We have previously identified sole 9, 13q- or 20q-, as favorable and sole 8 or complex karyotype as unfavorable cytogenetic abnormalities in primary myelofibrosis (PMF). In this study of 433 PMF patients, we describe additional sole abnormalities with favorable (chromosome 1 translocations/duplications) or unfavorable (7/7q-) prognosis and also show that other sole or two abnormalities that do not include i(17q), 5/5q-, 12p-, inv(3) or 11q23 rearrangement are prognostically aligned with normal karyotype, which is prognostically favorable. These findings were incorporated into a refined two-tired cytogenetic-risk stratification: unfavorable and favorable karyotype. The respective 5-year survival rates were 8 and 51% (hazard ratio (HR): 3.1, 95% confidence interval (CI): 2.2-4.3; P0.0001). Multivariable analysis confirmed the International Prognostic Scoring System (IPSS)-independent prognostic value of cytogenetic-risk categorization and also identified thrombocytopenia (platelets 100 × 109 /l) as another independent predictor of inferior survival (P0.0001). A similar multivariable analysis showed that karyotype (P0.001) and platelet count (P0.04), but not IPSS (P0.27), predicted leukemia-free survival; the 5-year leukemic transformation rates for unfavorable versus favorable karyotype were 46 and 7% (HR: 5.5, 95% CI: 2.5-12.0; P0.0001). This study provides the rationale and necessary details for incorporating cytogenetic findings and platelet count in future prognostic models for PMF.

Original languageEnglish (US)
Pages (from-to)82-88
Number of pages7
JournalLeukemia
Volume25
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Primary Myelofibrosis
Karyotype
Cytogenetics
Leukemia
Survival
Platelet Count
Confidence Intervals
Chromosomes, Human, Pair 1
Chromosome Aberrations
Thrombocytopenia
Blood Platelets
Survival Rate

Keywords

  • cytogenetics
  • karyotype
  • myelofibrosis
  • myeloproliferative
  • prognosis

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis : A single center study of 433 patients. / Caramazza, D.; Begna, Kebede; Gangat, N.; Vaidya, R.; Siragusa, S.; Van Dyke, D. L.; Hanson, C.; Pardanani, Animesh D; Tefferi, Ayalew.

In: Leukemia, Vol. 25, No. 1, 01.2011, p. 82-88.

Research output: Contribution to journalArticle

@article{0fa8584d511446bda8b2cbd17cebffa6,
title = "Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: A single center study of 433 patients",
abstract = "We have previously identified sole 9, 13q- or 20q-, as favorable and sole 8 or complex karyotype as unfavorable cytogenetic abnormalities in primary myelofibrosis (PMF). In this study of 433 PMF patients, we describe additional sole abnormalities with favorable (chromosome 1 translocations/duplications) or unfavorable (7/7q-) prognosis and also show that other sole or two abnormalities that do not include i(17q), 5/5q-, 12p-, inv(3) or 11q23 rearrangement are prognostically aligned with normal karyotype, which is prognostically favorable. These findings were incorporated into a refined two-tired cytogenetic-risk stratification: unfavorable and favorable karyotype. The respective 5-year survival rates were 8 and 51{\%} (hazard ratio (HR): 3.1, 95{\%} confidence interval (CI): 2.2-4.3; P0.0001). Multivariable analysis confirmed the International Prognostic Scoring System (IPSS)-independent prognostic value of cytogenetic-risk categorization and also identified thrombocytopenia (platelets 100 × 109 /l) as another independent predictor of inferior survival (P0.0001). A similar multivariable analysis showed that karyotype (P0.001) and platelet count (P0.04), but not IPSS (P0.27), predicted leukemia-free survival; the 5-year leukemic transformation rates for unfavorable versus favorable karyotype were 46 and 7{\%} (HR: 5.5, 95{\%} CI: 2.5-12.0; P0.0001). This study provides the rationale and necessary details for incorporating cytogenetic findings and platelet count in future prognostic models for PMF.",
keywords = "cytogenetics, karyotype, myelofibrosis, myeloproliferative, prognosis",
author = "D. Caramazza and Kebede Begna and N. Gangat and R. Vaidya and S. Siragusa and {Van Dyke}, {D. L.} and C. Hanson and Pardanani, {Animesh D} and Ayalew Tefferi",
year = "2011",
month = "1",
doi = "10.1038/leu.2010.234",
language = "English (US)",
volume = "25",
pages = "82--88",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis

T2 - A single center study of 433 patients

AU - Caramazza, D.

AU - Begna, Kebede

AU - Gangat, N.

AU - Vaidya, R.

AU - Siragusa, S.

AU - Van Dyke, D. L.

AU - Hanson, C.

AU - Pardanani, Animesh D

AU - Tefferi, Ayalew

PY - 2011/1

Y1 - 2011/1

N2 - We have previously identified sole 9, 13q- or 20q-, as favorable and sole 8 or complex karyotype as unfavorable cytogenetic abnormalities in primary myelofibrosis (PMF). In this study of 433 PMF patients, we describe additional sole abnormalities with favorable (chromosome 1 translocations/duplications) or unfavorable (7/7q-) prognosis and also show that other sole or two abnormalities that do not include i(17q), 5/5q-, 12p-, inv(3) or 11q23 rearrangement are prognostically aligned with normal karyotype, which is prognostically favorable. These findings were incorporated into a refined two-tired cytogenetic-risk stratification: unfavorable and favorable karyotype. The respective 5-year survival rates were 8 and 51% (hazard ratio (HR): 3.1, 95% confidence interval (CI): 2.2-4.3; P0.0001). Multivariable analysis confirmed the International Prognostic Scoring System (IPSS)-independent prognostic value of cytogenetic-risk categorization and also identified thrombocytopenia (platelets 100 × 109 /l) as another independent predictor of inferior survival (P0.0001). A similar multivariable analysis showed that karyotype (P0.001) and platelet count (P0.04), but not IPSS (P0.27), predicted leukemia-free survival; the 5-year leukemic transformation rates for unfavorable versus favorable karyotype were 46 and 7% (HR: 5.5, 95% CI: 2.5-12.0; P0.0001). This study provides the rationale and necessary details for incorporating cytogenetic findings and platelet count in future prognostic models for PMF.

AB - We have previously identified sole 9, 13q- or 20q-, as favorable and sole 8 or complex karyotype as unfavorable cytogenetic abnormalities in primary myelofibrosis (PMF). In this study of 433 PMF patients, we describe additional sole abnormalities with favorable (chromosome 1 translocations/duplications) or unfavorable (7/7q-) prognosis and also show that other sole or two abnormalities that do not include i(17q), 5/5q-, 12p-, inv(3) or 11q23 rearrangement are prognostically aligned with normal karyotype, which is prognostically favorable. These findings were incorporated into a refined two-tired cytogenetic-risk stratification: unfavorable and favorable karyotype. The respective 5-year survival rates were 8 and 51% (hazard ratio (HR): 3.1, 95% confidence interval (CI): 2.2-4.3; P0.0001). Multivariable analysis confirmed the International Prognostic Scoring System (IPSS)-independent prognostic value of cytogenetic-risk categorization and also identified thrombocytopenia (platelets 100 × 109 /l) as another independent predictor of inferior survival (P0.0001). A similar multivariable analysis showed that karyotype (P0.001) and platelet count (P0.04), but not IPSS (P0.27), predicted leukemia-free survival; the 5-year leukemic transformation rates for unfavorable versus favorable karyotype were 46 and 7% (HR: 5.5, 95% CI: 2.5-12.0; P0.0001). This study provides the rationale and necessary details for incorporating cytogenetic findings and platelet count in future prognostic models for PMF.

KW - cytogenetics

KW - karyotype

KW - myelofibrosis

KW - myeloproliferative

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=78651344350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651344350&partnerID=8YFLogxK

U2 - 10.1038/leu.2010.234

DO - 10.1038/leu.2010.234

M3 - Article

VL - 25

SP - 82

EP - 88

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -